Category Archives: SSRI Antidepressants

Featured Stories

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Fracking Releasing Hazardous Chemicals into Local Waterways

Fracking Releasing Hazardous Chemicals into Local Waterways

Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Study Finds Link Between Autism and Antidepressant Use During Pregnancy

A recent study found an increased risk of developing an autism spectrum disorder (ASD) in children whose mothers took specific antidepressant medications. The Swedish study stated that it found that “in utero exposure to both selective serotonin reuptake inhibitors (SSRIs) … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Good Information on Drug Safety in Pregnancy Hard to Find

While most pregnant women take medication at some point during pregnancy, it is difficult for them to find clear information about which drugs pose a risk to their unborn babies, such as antidepressants. Many drug labels provide few, if any, … Continue reading

Posted in Health Concerns, Pharmaceuticals, SSRI Antidepressants |

SSRI Antidepressants Linked to Cardiac Risks

We have long written about SSRI—selective serotonin reuptake inhibitors—antidepressants, medications that block the re-absorption (reuptake) of the neurotransmitter, serotonin, in the brain to boost mood. Now, emerging research reveals that some SSRIs pose cardiac risks. Research conducted by UK’s Medicines … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Paxil Birth Defects Lawsuits May Proceed

We’ve long written about SSRIs—selective serotonin reuptake inhibitors—such as Paxil, Prozac, Celexa, Lexapro, and Zoloft. SSRIs block the re-absorption (reuptake) of the neurotransmitter, serotonin, in the brain to boost mood. A judge has ruled that Paxil birth defect lawsuits can … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

SSRIs pose birth defects risks to pregnant women

New research shows selective serotonin reuptake inhibitor (SSRI) antidepressant drugs are dangerous when taken during pregnancy. According to a report from, researchers at Beth Israel Deaconess Medical Center and Tufts Medical Center have released a study showing many dangers of … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Study: Potential for Significant Risks with SSRIs and Pregnancy

A new study suggests that there is the potential for risks when taking SSRIs during pregnancy. SSRIs, or selective serotonin reuptake inhibitors include medications sold under the names Paxil, Prozac, Celexa, Lexapro, and Zoloft. SSRIs block the reabsorption (reuptake) of … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants |

Study analysis finds stroke risks among people taking SSRI antidepressants

A recent analysis of data available on the popular antidepressants known as selective serotonin reuptake inhibitors (SSRI) found a link between their use and an increased risk of a bleeding stroke. According to a report, the study from Western … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants | Tagged , , |

Driving on SSRI Antidepressants, Other Psychotropic Drugs, Increase Chances for Car Accidents

Taking antidepressants, including Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, as well as certain sleep aids and other psychotropic drugs, can increase the likelihood that an individual will suffer a motor vehicle accident, according to a new study in the British … Continue reading

Posted in Accident, Pharmaceuticals, SSRI Antidepressants | Tagged |

Glaxo to Resolve Avandia, Paxil, Wellbutrin Fraud Charges with Justice Department for Record-Breaking $3 Billion

The U.S. Justice Department has announced another record-breaking settlement with a pharmaceutical company accused of illegally marketing some of its drugs.  According to a statement issued by the Department late yesterday, GlaxoSmithKline will pay $3 billion to settle charges involving … Continue reading

Posted in Avandia, Pharmaceuticals, SSRI Antidepressants | Tagged |

Traces of SSRI Antidepressants in Drinking Water May Have Autism Link

Residues in drinking water from antidepressants and other drugs that impact the central nervous system may have a link to autism, according to a new study involving fish.  In an experiment conducted by researchers at the Idaho State University, minnows … Continue reading

Posted in Pharmaceuticals, SSRI Antidepressants | Tagged |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.